Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women aged 18 or older
- People who are planned to have a nipple-sparing mastectomy (a type of breast removal surgery that keeps the nipple) with immediate breast reconstruction
- People with a confirmed early-stage invasive breast cancer diagnosis (classified as cT1N0, meaning a small tumour with no lymph node involvement), or people who carry a gene mutation that increases cancer risk and are having a preventive mastectomy
- People with a small to medium breast size (classified as I–III) and without significant breast drooping
- People who are willing and able to sign a consent form agreeing to take part
Who may not be able to join:
- People with inflammatory breast cancer (a type that causes redness and swelling of the breast)
- People with a more advanced stage of breast cancer (classified as cT2–T4, or where cancer has spread to nearby lymph nodes)
- People whose diagnosis is ductal carcinoma in situ (DCIS) only, without any invasive cancer present
- People who have previously had radiotherapy to the affected breast
- People whose breast cancer has returned in the same area after previous treatment
- People whose general health or medical conditions make breast implant reconstruction unsuitable (confirm with trial site)
- People who are planned for a different type of mastectomy that involves removing or reducing the skin of the breast
- People who have received or are currently receiving chemotherapy before surgery
- People who are unwilling or unable to sign the consent form
- People who would not be able to attend all required follow-up appointments
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +39 02 57489 725
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Rate of completion of the procedure endoscopically without conversion to open surgery.; Surgery time; Feasibility of immediate reconstruction
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.